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http://dx.doi.org/10.1016/j.jfma.201Synovial sarcoma is a malignant soft tissue neoplasm that may arise from a variety of sites in
the human body. It is typically characterized by its biphasic histological pattern, but a mono-
phasic type composed entirely of spindle cells also exists. The diagnosis of monophasic synovial
sarcoma can be very challenging and often requires molecular diagnostic techniques, espe-
cially for tumors arising in rare locations such as the gastrointestinal tract. We report here
the case of a 38-year-old woman with a primary gastric monophasic synovial sarcoma
confirmed by reverse transcriptase polymerase chain reaction that revealed t(X;18) (SYT
eSSX1) translocation. To our knowledge, only 11 synovial sarcomas arising in the stomach have
previously been reported. The pathologic features, differential diagnoses, and clinical mani-
festations are discussed.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Synovial sarcoma is a malignant soft tissue neoplasm tradi-
tionally known for its biphasic histological pattern and
relatively high rate of occurrence near joints. The nomen-
clature is, however, actually a misnomer as no evidence of
differentiation toward synovium has been found and the
tumor can occur in almost any part of the body.1 Further,
many synovial sarcomas are of the monophasic type,
composed entirely of spindle cells, and can hardly bent of Pathology, National
an South Road, Taipei 10001,
com (J.-C. Lee).
ight ª 2012, Elsevier Taiwan LLC
2.07.010associated with synovium in terms of morphology.1 The
diagnosis of monophasic synovial sarcoma often requires
ancillary techniques such as immunohistochemical staining
and confirmatory molecular studies that reveal t(X;18)
resulting in a fusion of SYTwith SSX1, SSX2, or rarely SSX4.1,2
Primary gastric synovial sarcomas are extremely rare, only
11 cases having previously been reported in the English-
speaking literature.3,4 Here, we present a case of primary
gastric synovial sarcoma and review the related literature.
Case report
A 38-year-old woman presented with recent hunger pain
and passage of tarry stools. She had had a history of gastric
ulcer for more than 20 years and was receiving intermittent& Formosan Medical Association. All rights reserved.
Primary gastric synovial sarcoma 517medical treatment. Panendoscopy revealed groups of
polypoid lesions with ulceration (Fig. 1A). Mucosal biopsy
was performed, and histological examination revealed
a spindle cell malignancy. A subsequent barium study
showed an irregular mass, 7.5 cm in size, in the middle
portion of the body of the stomach (Fig. 1B). Abdominal and
chest computed tomography (CT) did not reveal any other
tumor lesions. There was no any clinical evidence of other
possible primary site. The patient underwent wedge
resection of the gastric tumor.
The surgical specimen demonstrated a yellow to gray-
white, firm mass measuring 7.2 cm 6.0 cm 2.7 cm in
size, with overlying ulceration (Fig. 2A). Grossly, the tumor
involved whole layers of the gastric wall. Microscopically,
the gastric tumor was hypercellular and composed of
spindle cells containing indistinct cytoplasm and uniform
nuclei with delicate to finely granular chromatin. The
tumor cells were arranged in long fascicles interlacing at
sharp angles and raggedly infiltrating the gastric wall from
the mucosa to the serosa (Fig. 2Be2D). Mitotic figures were
prominent (> 20 per 10 fields 400; Fig. 2F). Tumor thrombi
were noted in the medium-sized vessels (Fig. 2E). The
adjacent omentum also revealed foci of metastatic tumor.
In addition, no Helicobacter pylori bacilli was found in the
gastric mucosa.
Immunohistochemically, the tumor cells were focally
reactive to cytokeratin (AE1/AE3) and CD99 (Fig. 2G, 2H).
They were negative for c-KIT (despite highlightingFigure 1 (A) Endoscopic examination revealed a polypoid tumor
showed a mucosal filling defect in the middle portion of gastri
tomography 3 months after surgery revealed multiple hypoenhan
courses of chemotherapy, the metastatic foci significantly decreas
same level as in C.intermixed mast cells; Fig. 2I), CD34, discovered on GIST-1
protein (DOG1), cytokeratin 7, smooth muscle actin,
estrogen receptor, progesterone receptor, CD10 and Wilms’
tumor protein (WT-1). Reverse transcriptase-polymerase
chain reaction (RT-PCR) study revealed a chimeric tran-
script of SYTeSSX1 fusion gene (Fig. 3A), further confirmed
with complementary DNA sequencing (Fig. 3B).
Three months after the operation, follow-up abdominal
CT revealed multiple metastatic tumors in the liver (see
Fig. 1C). The patient received three courses of chemo-
therapy (ifosfamide 2000 mg/m2 and adriamycin 15 mg/m2
on the first to third days, repeated every 21e28 days).
Follow-up CT in the sixth postoperative month showed
dramatic shrinkage of the metastatic tumors in the liver
(Fig. 1D).Discussion
Synovial sarcoma is a malignant mesenchymal tumor that
tends to arise in the limbs, especially in the vicinity of the
knee joints,1 although it has been encountered in a wide
variety of locations, including the internal organs. It was
erroneously deemed a tumor of synovial differentiation,
probably due to the typically biphasic growth pattern
in addition to its usual juxta-articular location.5
However, monophasic fibrous synovial sarcomas composed
exclusively of spindle cells are sometimes encountered,with a lobulated appearance and ulceration. (B) Barium study
c body along the greater curvature (arrows). (C) Computed
ced metastatic foci in the right lobe of liver. (D) After three
ed in size as shown in follow-up computed tomography at the
Figure 2 (A) Gross picture of the gastric tumor. (B) The mucosa is involved by the tumor and ulcerated. H&E stain,12.5. (C) The
tumor is invading the gastric wall with an infiltrative border. H&E, 40. (D) The omental fat is also involved. H&E, 40. (E) Vascular
invasion is present. H&E, 100. (F) The tumor cells are uniformly spindle-shaped with brisk mitotic figures. H&E, 200. The tumor
cells are focally immunoreactive to cytokeratin (AE1/AE3) (G) and CD99 (H). (I) c-KIT is positive in the scattered mast cells but not
the tumor cells.
518 C.-C. Wang et al.and these can cause significant diagnostic problems if
immunohistochemical or genetic studies are not carried
out. Immunohistochemically, synovial sarcomas are often
focally reactive to cytokeratins and/or epithelial
membrane antigen,1 evidencing the epithelial differentia-
tion. Immunohistochemistry plays an important and often
efficient role in distinguishing synovial sarcomas from
tumors that mimic them, although some pitfalls should be
kept in mind, as discussed below.
When a pathologist deals with a spindle cell tumor arising
in the gastrointestinal tract, gastrointestinal stromal tumors
(GIST) usually spring to mind first. These are composed of
short spindle and/or epithelioid cells often with vacuolated
cytoplasm, sometimes exhibiting nuclear palisading,
features that were not seen in the present case. Commonly,
one can differentiate a GIST from synovial sarcoma as c-KIT
(CD117) is expressed in most GISTs, although c-KIT also
stains mast cells, which are often numerous in synovial
sarcomas (see Fig. 2I). Leiomyosarcomas and malignant
spindle cell melanomas are characterized by a higher
degree of pleomorphism, and a panel of smooth muscle
markers and melanocytic markers, respectively, can usually
confirm the diagnoses. Sarcomatoid carcinoma often
exhibits conspicuous pleomorphism and a higher level of
epithelial markers, and is usually accompanied by conven-
tional carcinoma. Regardless of the peculiar location, the
chief mimickers are malignant peripheral nerve sheathtumor and fibrosarcoma, especially the former in terms of
overlapping in immunoprofile.6e8 Further, synovial sarcoma
can occasionally mimic a Ewing’s sarcoma or malignant
solitary fibrous tumor.1 In brief, the morphology and
immunoprofile can often distinguish these mimickers from
synovial sarcomas, but molecular genetic studies may be
needed for confirmation in difficult cases.
The unique chromosomal change at t(X;18) with resul-
tant SYTeSSX fusion genes is both sensitive and specific to
synovial sarcoma, and can be effectively detected in
formalin-fixed, paraffin-embedded tissue using RT-PCR.9,10
As discussed earlier, detection of these translocations is
often necessary for the diagnosis of monophasic synovial
sarcomas, especially for those arising in unusual sites,
perfectly exemplified by the current case.
To date, only 23 cases of primary synovial sarcomas in
gastrointestinal tract have been reported in the English
literature3,4,11e14, and 11 of these have arisen in the
stomach (Table 1). Nine of the 11 primary gastric tumors
and both duodenal tumors were of the monophasic fibrous
type, and most of them were confirmed with RT-PCR or
fluorescence in situ hybridization. These gastrointestinal
monophasic synovial sarcomas have been reported in only
the past few years, probably reflecting the fact that a wider
application of immunohistochemistry and molecular tech-
niques, as well as a growing awareness of the existence of
visceral counterparts, has increasingly identified these
Figure 3 (A) Results of reverse transcriptase polymerase chain reaction in four cases. Case 1: positive control for SYTeSSX1
translocation. Case 2: positive control for SYTeSSX2 translocation. Case 3: a case of malignant peripheral nerve sheath tumor
(serving as a negative control). *Case 4: the present case. A dense band of chimeric transcript of the SYTeSSX1 fusion gene (left
part), but not SYTeSSX2 (right part), is shown. (B) The fusion point of the SYTeSSX1 gene is demonstrated with cDNA sequencing.
Primary gastric synovial sarcoma 519unusually located tumors that might have been mis-
diagnosed as other spindle cell tumors in the past.
Although the mainstay of treatment for synovial
sarcomas is surgical resection with or without radiationTable 1 Clinical features and outcomes of reported cases of ga
Case Age Sex Size (cm) Site Ad
1 67 F 0.8 Bodyeantrum junction Ni
2 49 M 2 Body Ni
3 68 F 2 Body Ni
4 29 M 2.8 Body Ni
5 54 F 3 Antrum to gastroduodenal
junction
Ni
6 58 F 3 Body Ni
7 37 F 4 Fundus Ni
8 50 M 6 Distal fundus Ch
9 42 M 8 Body Ch
10 66 F 15 Fundus Ni
11 55 F 16 Antrum Ni
12 38 F 7.2 Body Ch
ANED Z alive without evidence of disease; DOD Z died of disease; Dtherapy to enhance local control, patients with primary
extremity tumors greater than 5 cm in size or metastatic
lesions have been shown to benefit from adjuvant chemo-
therapy using an ifosfamide-based regimen.15,16 The latterstric synovial sarcoma.
juvant therapy Outcome Reference
l ANED, 12 mo Makhlouf et al3
l DOD (omental
metastases), 29 mo
Makhlouf et al 3
l ANED, 22 mo Makhlouf et al 3
l ANED, 224 mo Makhlouf et al 3
l Not provided (recent
case at the time of
publication)
Makhlouf et al 3
l ANED, 21 mo Makhlouf et al 3
l Local recurrence,
DOO, 48 mo
Makhlouf et al 3
emotherapy AWD (recurrence),
6 mo
Makhlouf et al 3
emotherapy DOD, 25 mo Makhlouf et al 3
l Lost to follow-up Makhlouf et al 3
l DOD, 6 mo Billings et al 4
emotherapy AWD (liver metastasis),
6 mo
Current case
OO Z died of other causes; AWD Z alive with disease.
520 C.-C. Wang et al.indeed produced a striking short-term effect on the meta-
static tumors in our case, although its general benefit in
gastrointestinal cases remains to be determined. Only
three cases with gastric tumors have received chemo-
therapy, one being the current case; the regimens in the
two cases are unclear, and radiation therapy was not per-
formed in any of the 12 patients (Table 1). Parenthetically,
the relative chemosensitivity of synovial sarcomas in
comparison with other sarcomas highlights the importance
of accurate diagnosis of this entity.
The clinical outcome of patients with synovial sarcoma
in the extremities is significantly related to tumor size and
local invasion status－larger tumor size (>5 cm) and inva-
sion of bone, nerves, or vessels are correlated with a worse
prognosis.15 The prognosticative power of tumor size also
seems to hold true for the gastric counterparts, as four of
the six patients with tumors smaller than 5 cm had an
uneventful postoperative course, whereas none of the four
patients with larger tumors did.
Conclusion
Primary synovial sarcoma of the gastrointestinal tract is
rare and prone to misdiagnosis. When facing a malignant
spindle cell tumor of the gastrointestinal tract, synovial
sarcoma should not be neglected when listing the differ-
ential diagnoses. The use of molecular techniques such as
RT-PCR to detect the pathognomonic translocation is the
key to making a correct diagnosis in doubtful cases and
hence providing them with adequate treatment.
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